Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mundipharma (China) Pharmaceutical Co., Ltd., known locally as Mengdi, is a leading pharmaceutical company specializing in pain management, oncology, and respiratory health. Since its establishment in 1993, the company has been a pioneer in introducing advanced analgesic therapies and standardized pain management protocols to the Chinese healthcare system. Its core portfolio includes well-known brands such as OxyContin, Targin, and Norspan, which are essential for treating chronic and cancer-related pain. Mundipharma China operates a significant manufacturing base in Beijing and maintains a comprehensive commercial infrastructure across the country. Beyond its leadership in pain, the company has expanded into consumer health with the antiseptic brand Betadine and continues to grow its presence in the respiratory and anti-infective markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 萌蒂.